Related Experiment Video
Updated: Jul 9, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
Rational strategies for designing next-generation oncolytic viruses based on transcriptome analysis of tumor cells
Naeme Javid1, Shahriyar Abdoli2, Majid Shahbazi3,4
1Department of Molecular Medicine, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Introduction:
Oncolytic herpes simplex viruses (oHSVs) are a type of biotherapeutic utilized in cancer therapy due to their ability to selectively infect and destroy tumor cells without harming healthy cells. We sought to investigate the functional genomic response and altered metabolic pathways of human cancer cells to oHSV-1 infection and to elucidate the influence of these responses on the relationship between the virus and the cancer cells.
Methods:
Two datasets containing gene expression profiles of tumor cells infected with oHSV-1 (G207) and non-infected cells from the Gene Expression Omnibus (GEO) database were processed and normalized using the R software. Common differentially expressed genes between datasets were selected to identify hub genes and were further analyzed. Subsequently, the expression of hub genes was verified by real-time polymerase chain reaction (qRT-PCR) in MDA-MB-231 (a breast cancer cell line) infected with oHSV-1 and non-infected cells.
Results:
The results of our data analysis indicated notable disparities in the genes associated with the proteasome pathway between infected and non-infected cells. Our ontology analysis revealed that the proteasome-mediated ubiquitin-dependent protein catabolic process was a significant biological process, with a p-value of 5.8E-21. Additionally, extracellular exosomes and protein binding were identified as significant cellular components and molecular functions, respectively. Common hub genes with degree and maximum neighborhood component (MNC) methods, including PSMD2, PSMD4, PSMA2, PSMD14, PSMD11, PSMC3, PSMC2, PSMD8, and PSMA4, were also identified. Analysis of gene expression by qRT-PCR and differential gene expression revealed that GADD45g genes can be effective genes in the proliferation of oncolytic HSV-1 virus.
Conclusion:
The transcriptome changes in tumor cells infected by oHSV-1 may be utilized to predict oncolytic efficacy and provide rational strategies for designing next-generation oncolytic viruses.
Insights
Oncolytic herpes simplex viruses (oHSVs) target cancer cells. This study analyzed gene expression changes in oHSV-1 infected cells, identifying proteasome pathway alterations and key genes like GADD45g for potential therapeutic strategies.
Area of Science:
- Oncology
- Virology
- Genomics
- Systems Biology
Background:
- Oncolytic herpes simplex viruses (oHSVs) are promising biotherapeutics for cancer treatment, selectively targeting and destroying tumor cells.
- Understanding the host cell's genomic and metabolic response to oHSV infection is crucial for optimizing their therapeutic efficacy.
Purpose of the Study:
- To investigate the functional genomic and metabolic pathway alterations in human cancer cells upon infection with oHSV-1.
- To identify key genes and pathways influenced by oHSV-1 infection that modulate the virus-cancer cell interaction.
- To explore the potential of transcriptome changes for predicting oncolytic virus efficacy.
Main Methods:
- Utilized two gene expression datasets from the Gene Expression Omnibus (GEO) database for tumor cells infected with oHSV-1 (G207) and control cells.
- Processed and normalized data using R software, identifying common differentially expressed genes and hub genes.
- Validated hub gene expression using real-time quantitative polymerase chain reaction (qRT-PCR) in MDA-MB-231 breast cancer cells.
Main Results:
- Significant alterations in proteasome pathway-related genes were observed between infected and non-infected cells, with the proteasome-mediated ubiquitin-dependent protein catabolic process identified as a key biological pathway (p-value: 5.8E-21).
- Extracellular exosomes and protein binding were identified as significant cellular components and molecular functions, respectively.
- Key hub genes including PSMD2, PSMD4, PSMA2, and GADD45g were identified, with GADD45g showing potential in oncolytic HSV-1 proliferation.
Conclusions:
- Transcriptome analysis reveals significant host cell responses to oHSV-1 infection, particularly involving the proteasome pathway.
- Identified hub genes and pathways provide insights into the virus-cancer cell dynamics.
- These findings can inform the development of next-generation oncolytic viruses and predict their therapeutic efficacy.
Related Concept Videos
Size and Structure of Viral Genomes
Viruses with RNA Genomes
Herpes
Antiviral Nucleoside Inhibitors

